Filing Details
- Accession Number:
- 0001209191-14-030568
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-02 14:41:24
- Reporting Period:
- 2014-05-01
- Filing Date:
- 2014-05-02
- Accepted Time:
- 2014-05-02 14:41:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1415336 | Zeltiq Aesthetics Inc | ZLTQ | Electromedical & Electrotherapeutic Apparatus (3845) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1417977 | C Leonard Debenedictis | 4698 Willow Road, Suite 100 Pleasanton CA 94588 | Chief Technology Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-05-01 | 2,500 | $6.50 | 71,393 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-05-01 | 2,500 | $18.01 | 68,893 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-05-01 | 2,500 | $0.00 | 2,500 | $6.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 125,000 | 2022-10-07 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 7,572 | Indirect | LEN C. DEBENEDICTIS TTEE LEN C. DEBENEDICTIS CHARITABLE REM. UNITRUST U/A DTD 08/03/1995 |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 18, 2014.
- 25% of the total number of shares subject to the option vested on October 8, 2013, and the remainder vest in equal monthly installments over a 36 month period thereafter, subject to the Reporting Person's continued service to the Issuer.
Billionaire Hedge Funds
